A private healthcare facility in London co-managed by its consultants is expanding as the NHS struggles
Slashed US aid agency’s funding is expected to harm the fight against diseases including malaria and HIV/Aids
Birmingham scheme offers national template but cultural shake-up needed to make it work, health leaders warn
Companies are filling the gap left by the NHS in bid to keep staff at work
Cost-cutting by consumers and trendy high protein diets are driving sales like never before
Cost and complexity deter people from buying medical insurance
Tech companies already embedded in people’s lives have the best chance of not becoming a fad
How users treat a product in the real world can diverge wildly from what the designers intended
Move exacerbates Gavi’s struggles with fundraising
Delayed blood test result contributed to person dying after 2024 ransomware attack
Oxford research shows adjuvant chemicals included in vaccinations may enhance their antiviral effect
Expert advice on finding the right racket for you, as well as the best balls and shoes — and tips to avoid tennis elbow
Sneakers, hiking shoes and... flip-flops for that barely-there fit
The decline in funding for vaccinations poses a worldwide threat
Three decades after her first pimple, one writer has spent thousands of pounds in the pursuit of clear skin. What worked?
Unicef says children are dying ‘without a doubt’ across strip because of Israeli aid blockade
And who could have anticipated this turn of events apart from literally anyone?
Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments
Ten worst performing maternity and neonatal units to be ‘urgently’ examined, says health department
Players in the know are sidestepping the capital’s jam-packed tennis courts — and eye-watering private club fees — by joining crews focused on community and fun where everyone’s welcome
The former world number one tennis player discusses motherhood, tennis and business
Danish group lost €90bn in market capitalisation in December after preliminary results showed it missed its target
Ministers argue unpopular cuts to welfare payments are part of mission to get people into work and off benefits
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
From politics, economics and history to art, food and, of course, fiction — FT writers and critics choose their favourite reads of the year so far
